Effects of Abciximab on Coronary Restenosis
Author Information
Author(s): Rainer Voisard, Alan Mustafa, Lutz von Müller, Regine Baur, Vinzenz Hombach
Primary Institution: University of Ulm
Hypothesis
Does abciximab affect ICAM-1 expression, migration, and proliferation in human vascular cells?
Conclusion
Abciximab does not directly inhibit ICAM-1 expression, migration, or proliferation in human vascular cells.
Supporting Evidence
- Abciximab had no effect on ICAM-1 expression in human vascular cells.
- Abciximab stimulated migration of smooth muscle cells at certain concentrations.
- Small but significant antiproliferative effects were observed in endothelial and smooth muscle cells.
Takeaway
This study looked at how a drug called abciximab affects certain cells in the heart. It found that the drug doesn't stop these cells from growing or moving, which is important for heart health.
Methodology
The study used cytoflow studies to assess ICAM-1 expression, migration assays for smooth muscle cells, and proliferation assays for endothelial cells.
Limitations
The study did not include platelets or other cellular components that may influence the results.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website